Standout Papers

Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multi... 2016 2026 2019 2022 478
  1. Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study (2016)
    Scott Antonia, Sarah B. Goldberg et al. The Lancet Oncology

Citation Impact

5 by Nobel laureates 32 from Science/Nature 62 standout
Sub-graph 1 of 22

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Tertiary lymphoid structures in anticancer immunity
2024 Standout
6 intermediate papers

Works of Keith E. Steele being referenced

Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients
2021
Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapy
2019
and 1 more

Author Peers

Author Oncology Infectious Diseases PHEOH Last Decade Papers Cites
Keith E. Steele 1247 1547 661 71 3.5k
C. G. Guttridge 1 33 709
Eugene Zimmerman 1 3 405 7 877
Mohammad Reza Pourjavid 10 1 40 903
Burak Pirgaip 27 263
Zakia Belhadj 22 13 5 9 470

All Works

Loading papers...

Rankless by CCL
2026